Supply Chain

Company targets evolving regenerative medicine market

$4.8-billion deal follows UPS' failed effort in 2013

2015 spring meeting focuses on meeting transportation bottlenecks

Unifying the management of clinical research documentation and marketing content saves time and accelerates speed-to-therapy

GDP standards drive higher performance standards for packaging

Poltraf acquisition adds to a network of 14 facilities serving Eastern and Western Europe

The broad changes taking place in the pharma supply chain this year are a relevant focus for the annual conference and exhibition

FDA enforcement delay to May 1 isn't slowing down project work

Company hires Kevin O'Donnell, cold chain expert, to build out its Biologistex shipping service

Regulatory compliance continues to exceed cost as a primary driver

Airport will organize client carriers to meet new IATA standards

Tracking systems dominate product introductions

DHL garners headlines with a 'parcelcopter' delivering daily drugs to remote North Sea island

Often, needless cost and complexity--without improving quality and safety--impede cold chain packaging planning

Service providers are building out a wider range of services to meet drug developers' needs

Meanwhile, competitor CSafe Global broadens its containers' usability

The drive for lower costs, safer products

Never a better time to connect, listen, learn and share

Closer tracking of small-parcel shipments helps meet regulatory requirements

Organization hires BSI Supply Chain Solutions to lead international joint audit program

Certis pallet shipper employs new convection features and simplified preparation steps

Infosys/Lodestone upgrade integrates with SAP systems for managing closer collaborations with trial partners

Authorization enables the Frankfurt depot to ship to non-EU countries without filing EU paperwork

There is new evidence that cold storage systems used for clinical products and samples is at risk from poorly designed, installed or maintained refrigeration systems. Here's what to do about it.

Products could cut time-to-market in injectables R&D